Arthritis, Rheumatoid: all 2,962 studies

Page 26 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)CompletedNCT01217086Phase 3
• A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid ArthritisCompletedNCT01214733Phase 3
• The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis PatientsCompletedNCT01213017Phase 3
• Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01211834Phase 3
• Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive PatientsCompletedNCT01211678
• GLPG0259 in Methotrexate-refractory Rheumatoid ArthritisCompletedNCT01211249Phase 2
• First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid ArthritisCompletedNCT01208506Phase 1
• Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC TrialCompletedNCT01205854Phase 4
• Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARAWithdrawnNCT01204138Phase 2
• Pain Modulation in Rheumatoid Arthritis (RA) - Influence of AdalimumabCompletedNCT01197144Not applicable
• Open-label, Extension Study of CDP870 in Patients With Rheumatoid ArthritisCompletedNCT01197066Phase 3
• An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)TerminatedNCT01196780
• An Observational Study on Long-Term Effectiveness and Safety of RoActemra/Actemra (Tocilizumab) in Daily Practice in Patients With Rheumatoid Arthritis (ICHIBAN)Status unknownNCT01194401
• A Study of Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT01187563
• A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)CompletedNCT01184092Phase 1
• A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy SubjectsCompletedNCT01184001Phase 1
• Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol BalanceCompletedNCT01180361
• n-3 and n-6 Fatty Acids in Rheumatoid ArthritisCompletedNCT01179971Phase 2
• Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic DisorderCompletedNCT01176682
• Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on BiologicsCompletedNCT01166620
• Periodontal Disease and P. Gingivalis in Rheumatoid ArthritisCompletedNCT01156155
• Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity SyndromesStatus unknownNCT01154647Not applicable
• Dose Escalation With Remicade® and Orencia®CompletedNCT01141413
• A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal InjuryCompletedNCT01140828Phase 3
• Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis PatientsCompletedNCT01137851
• Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic AgentsCompletedNCT01137838
• Predictors of Adherence to OrenciaCompletedNCT01136707
• Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)CompletedNCT01136694
• TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive DrugsCompletedNCT01131910Phase 2
• Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After DiscontinuationCompletedNCT01120366Phase 4
• A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR)TerminatedNCT01117129Phase 4
• A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)CompletedNCT01116141Phase 2
• Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid ArthritisCompletedNCT01111357
• Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid ArthritisCompletedNCT01105715
• Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis DesignCompletedNCT01102829
• Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy StudyCompletedNCT01101555Phase 1
• Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)CompletedNCT01098201
• Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With RituximabStatus unknownNCT01096069
• National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)CompletedNCT01095393
• Safety Study of Abatacept in SwedenCompletedNCT01094795
• Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving MethotrexateWithdrawnNCT01090570Phase 1
• Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)Active, not recruitingNCT01088360
• Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)CompletedNCT01088321
• Abatacept Pregnancy Exposure RegistryCompletedNCT01087125
• OTIS Humira Pregnancy RegistryCompletedNCT01086059
• Golimumab Safety and Surveillance Program Using the Ingenix NHI DatabaseCompletedNCT01081717
• A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RACompletedNCT01078597
• Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid ArthritisTerminatedNCT01077531Phase 1
• Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)CompletedNCT01075711
• An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)CompletedNCT01075477
• Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF BlockerStatus unknownNCT01072058Phase 4
• Association of Fear of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological TherapyStatus unknownNCT01071863
• Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and RepositoryCompletedNCT01070121
• Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)WithdrawnNCT01067430Phase 4
• Psychosocial Treatment Intervention in Persons Newly Diagnosed With Rheumatoid Arthritis or DiabetesCompletedNCT01066130Not applicable
• Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee ImplantsCompletedNCT01064063Not applicable
• Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid ArthritisCompletedNCT01063803Phase 2
• Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid ArthritisCompletedNCT01055899Phase 1
• A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid ArthritisCompletedNCT01052194Phase 2
• The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary StudyStatus unknownNCT01050010Not applicable
• Use of Thermal and 3D Imaging to Quantify ArthritisCompletedNCT01044823
• Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa AntagonistsCompletedNCT01040715Phase 2
• Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid ArthritisCompletedNCT01038674Phase 1
• Applications for Methotrexate Optimization in Rheumatoid ArthritisCompletedNCT01038349
• Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating BiomarkersCompletedNCT01029613
• Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid ArthritisCompletedNCT01027728Phase 1/2
• A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid ArthritisCompletedNCT01026519Phase 1
• A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product TestersCompletedNCT01023100Phase 1
• Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic TherapyCompletedNCT01021735Phase 4
• Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01017367Phase 2
• A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis SubjectsCompletedNCT01011959Phase 1
• SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01010581Phase 2
• Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow EmigrantsWithdrawnNCT01009879Phase 4
• To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using MethotrexateCompletedNCT01009242Phase 1/2
• Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid ArthritisCompletedNCT01008852Phase 2
• Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid ArthritisCompletedNCT01007175Phase 1/2
• Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid ArthritisStatus unknownNCT01002716Phase 4
• Health Outcomes in Rheumatoid Arthritis in GreeceCompletedNCT01001182
• Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisCompletedNCT01000441Phase 4
• Atherosclerosis in Rheumatoid ArthritisCompletedNCT00990730
• Rheumatoid Arthritis Disease Activity MonitorCompletedNCT00989677
• Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical PracticeStatus unknownNCT00984711
• A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis PatientsWithdrawnNCT00979771Phase 2
• Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid ArthritisCompletedNCT00969527Phase 3
• Improving Beliefs About Medication in Patients With Rheumatoid ArthritisCompletedNCT00968266Not applicable
• Effect of Healing on Rheumatoid ArthritisCompletedNCT00967395Not applicable
• A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT00965653Phase 1
• Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid ArthritisCompletedNCT00963703Not applicable
• Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid ArthritisCompletedNCT00959036Phase 1/2
• Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive DrugsStatus unknownNCT00947492Not applicable
• Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in TaiwanCompletedNCT00944320
• Pharmacogenetics of Antifolate Drugs in Autoimmune Diseases in TaiwanCompletedNCT00944255
• An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid ArthritisTerminatedNCT00941707Phase 2
• Evaluation of the BRADA and ABILHAND QuestionnairesCompletedNCT00938444
• Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99No longer availableNCT00931086
• Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateTerminatedNCT00928317Phase 2
• Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha TherapyStatus unknownNCT00925249
• The Use of Neuromuscular Electrical Stimulation to Reverse Muscle Atrophy in Patients With Rheumatoid ArthritisCompletedNCT00924625Not applicable
• A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis PatientsWithdrawnNCT00920608Phase 1
• Targeting Synovitis in Early Rheumatoid ArthritisStatus unknownNCT00920478Phase 4

← Arthritis, Rheumatoid overview